Curzio Rüegg

1.6k total citations
17 papers, 1.3k citations indexed

About

Curzio Rüegg is a scholar working on Immunology and Allergy, Molecular Biology and Pharmacology. According to data from OpenAlex, Curzio Rüegg has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology and Allergy, 10 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Curzio Rüegg's work include Cell Adhesion Molecules Research (13 papers), Angiogenesis and VEGF in Cancer (7 papers) and Inflammatory mediators and NSAID effects (7 papers). Curzio Rüegg is often cited by papers focused on Cell Adhesion Molecules Research (13 papers), Angiogenesis and VEGF in Cancer (7 papers) and Inflammatory mediators and NSAID effects (7 papers). Curzio Rüegg collaborates with scholars based in Switzerland, France and Russia. Curzio Rüegg's co-authors include Olivier Dormond, Gian Carlo Alghisi, Agnese Mariotti, Alessandro Foletti, Cécile Paroz, Jelena Zarić, Meriem Hasmim, Grégory Bieler, Roger Stupp and Philippe Olivier and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and PLoS ONE.

In The Last Decade

Curzio Rüegg

17 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Curzio Rüegg Switzerland 16 603 431 300 292 229 17 1.3k
L. C. Tetlow United Kingdom 18 418 0.7× 181 0.4× 224 0.7× 250 0.9× 357 1.6× 23 1.5k
Kasper Almholt Denmark 19 918 1.5× 251 0.6× 509 1.7× 143 0.5× 755 3.3× 33 2.0k
Kozłowski Jm United States 3 844 1.4× 417 1.0× 565 1.9× 68 0.2× 504 2.2× 9 1.7k
Jaume Piulats Spain 17 685 1.1× 490 1.1× 273 0.9× 32 0.1× 186 0.8× 30 1.2k
Andreas Menrad Germany 20 682 1.1× 162 0.4× 513 1.7× 44 0.2× 206 0.9× 30 1.5k
Elisabetta Rovida Italy 28 1.1k 1.8× 180 0.4× 395 1.3× 55 0.2× 365 1.6× 78 2.0k
Robin V. Ward United Kingdom 18 761 1.3× 302 0.7× 769 2.6× 150 0.5× 1.2k 5.4× 26 2.3k
Takatomo Koshiba Japan 16 658 1.1× 158 0.4× 856 2.9× 80 0.3× 318 1.4× 29 1.5k
Habib Boukerche France 20 809 1.3× 265 0.6× 504 1.7× 36 0.1× 196 0.9× 33 1.6k
Tanguy Lechertier United Kingdom 15 630 1.0× 236 0.5× 261 0.9× 38 0.1× 239 1.0× 17 1.1k

Countries citing papers authored by Curzio Rüegg

Since Specialization
Citations

This map shows the geographic impact of Curzio Rüegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curzio Rüegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curzio Rüegg more than expected).

Fields of papers citing papers by Curzio Rüegg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curzio Rüegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curzio Rüegg. The network helps show where Curzio Rüegg may publish in the future.

Co-authorship network of co-authors of Curzio Rüegg

This figure shows the co-authorship network connecting the top 25 collaborators of Curzio Rüegg. A scholar is included among the top collaborators of Curzio Rüegg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curzio Rüegg. Curzio Rüegg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Missiaglia, Edoardo, et al.. (2011). MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells. Oncogene. 31(12). 1521–1532. 42 indexed citations
2.
Rüegg, Curzio & Gian Carlo Alghisi. (2009). Vascular Integrins: Therapeutic and Imaging Targets of Tumor Angiogenesis. Recent results in cancer research. 180. 83–101. 58 indexed citations
4.
Alghisi, Gian Carlo & Curzio Rüegg. (2006). Vascular Integrins in Tumor Angiogenesis: Mediators and Therapeutic Targets. Endothelium. 13(2). 113–135. 124 indexed citations
5.
Kalyuzhniy, Oleksandr, Orbicia Riccio, Sergey A. Potekhin, et al.. (2005). Synthetic RGD-containing α-helical coiled coil peptides promote integrin-dependent cell adhesion. Journal of Peptide Science. 12(3). 206–212. 40 indexed citations
7.
Zarić, Jelena & Curzio Rüegg. (2004). Integrin-mediated Adhesion and Soluble Ligand Binding Stabilize COX-2 Protein Levels in Endothelial Cells by Inducing Expression and Preventing Degradation. Journal of Biological Chemistry. 280(2). 1077–1085. 48 indexed citations
8.
Doucey, Marie‐Agnès, Daniel F. Legler, Mustapha Faroudi, et al.. (2003). The β1 and β3 Integrins Promote T Cell Receptor-mediated Cytotoxic T Lymphocyte Activation. Journal of Biological Chemistry. 278(29). 26983–26991. 58 indexed citations
9.
Hasmim, Meriem, et al.. (2003). Zoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-induced Programmed Cell Death. Journal of Biological Chemistry. 278(44). 43603–43614. 118 indexed citations
10.
Dormond, Olivier & Curzio Rüegg. (2003). Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase A. Thrombosis and Haemostasis. 90(10). 577–585. 36 indexed citations
11.
Rüegg, Curzio, Olivier Dormond, & Agnese Mariotti. (2003). Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1654(1). 51–67. 95 indexed citations
12.
Rüegg, Curzio, Jelena Zarić, & Roger Stupp. (2003). Non steroidal anti‐inflammatory drugs and COX‐2 inhibitors as anti‐cancer therapeutics: hypes, hopes and reality. Annals of Medicine. 35(7). 476–487. 65 indexed citations
13.
Dormond, Olivier, et al.. (2002). Prostaglandin E2 Promotes Integrin αVβ3-dependent Endothelial Cell Adhesion, Rac-activation, and Spreading through cAMP/PKA-dependent Signaling. Journal of Biological Chemistry. 277(48). 45838–45846. 131 indexed citations
14.
Rüegg, Curzio, et al.. (2001). Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives. Drug Resistance Updates. 4(5). 314–321. 42 indexed citations
15.
Dormond, Olivier, Alessandro Foletti, Cécile Paroz, & Curzio Rüegg. (2001). NSAIDs inhibit αVβ3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nature Medicine. 7(9). 1041–1047. 237 indexed citations
16.
Rüegg, Curzio, Olivier Dormond, Delphine Oguey, & Ferdy J. Lejeune. (2000). Tumor necrosis factor: clinical use and mechanisms of action. Drug Resistance Updates. 3(5). 271–276. 8 indexed citations
17.
Hauzenberger, Dan, Philippe Olivier, Doris Gundersen, & Curzio Rüegg. (1999). Tenascin-C inhibits β1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1 – 5 repeats to fibronectin. European Journal of Immunology. 29(5). 1435–1447. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026